临床荟萃 ›› 2025, Vol. 40 ›› Issue (7): 624-633.doi: 10.3969/j.issn.1004-583X.2025.07.007
收稿日期:2025-03-07
出版日期:2025-07-20
发布日期:2025-07-17
通讯作者:
崔清洋
E-mail:1282592772@qq.com
Wang Xiaofang1,2, Cui Qingyang1(
), Liu Xinyu3
Received:2025-03-07
Online:2025-07-20
Published:2025-07-17
Contact:
Cui Qingyang
E-mail:1282592772@qq.com
摘要:
目的 探讨血小板及白细胞参数对早产儿并发支气管肺发育不良(bronchopulmonary dysplasia, BPD)的预测意义并构建logistic回归预测模型。方法 选择2019年10月-2024年10月新乡医学院第一附属医院和晋城市人民医院新生儿科及NICU收治的胎龄≤32周的早产儿病历资料进行回顾性分析,根据是否发生BPD分为BPD组和非BPD组,比较两组一般资料及24 h、1周、2周、4周的血小板及白细胞参数,将差异有统计学意义的一般情况和血小板及白细胞参数进行logistic回归分析建立预测模型,并采用受试者工作特征曲线对该模型进行验证。结果 共纳入258例早产儿,93例发生BPD,发生率为36%(93/258);一般情况:BPD组男性多于非BPD组(P<0.05); BPD组住院时间长于非BPD组(P<0.05);BPD组胎龄小于非BPD组(P<0.05);BPD组出生体重小于非BPD组(P<0.05);BPD组1min和5min的Apgar评分均小于非BPD组(P<0.05); BPD组无创及有创呼吸机使用时间均长于非BPD组(P<0.05);BPD组肺泡表面活性物质使用占比较非BPD组多;BPD组更易出现合并疾病(动脉导管未闭、早产儿视网膜病、新生儿持续性肺动脉高压)(P<0.05)。血小板及白细胞参数:BPD组2周时血小板计数低于非BPD组(P<0.05);BPD组1周时平均血小板体积大于非BPD组;BPD组24 h血小板分布宽度小于非BPD组(P<0.05);BPD组4周时中性粒细胞计数大于非BPD组(P<0.05);BPD组24 h淋巴细胞计数小于非BPD组(P<0.05);BPD组24 h、2周、4周时中性粒细胞与淋巴细胞比值均大于非BPD组(P<0.05);BPD组24 h血小板与淋巴细胞比值大于非BPD组(P<0.05);BPD组2周时血小板质量指数小于非BPD组(P<0.05)。选择独立因素分析中差异有统计学意义的一般情况和24 h的血小板、白细胞参数构建logistic回归风险预测模型,该模型预测早产儿发生BPD的曲线下面积为0.783(95%CI:0.724~0.842)。结论 24 h血小板、白细胞参数可作为BPD发生早期的预测指标,基于上述因素构建logistic回归预测模型具有较高预测价值。
中图分类号:
王晓芳, 崔清洋, 刘新宇. 血小板及白细胞参数对早产儿并发支气管肺发育不良预测价值[J]. 临床荟萃, 2025, 40(7): 624-633.
Wang Xiaofang, Cui Qingyang, Liu Xinyu. Predictive value of platelet and white blood cell parameters for bronchopulmonary dysplasia in premature infants[J]. Clinical Focus, 2025, 40(7): 624-633.
| 组别 | 例数 | 性别[例(%)] | 住院时间 (d) | 胎龄 (d) | 出生体重 (g) | 母孕期合并疾病[例(%)] | 母绒毛膜羊膜炎[例(%)] | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 是 | 否 | 是 | 否 | ||||||||||||||||||||||||||||
| BPD组 | 93 | 61(65.6) | 32(34.4) | 54.91±16.19 | 204.11±12.59 | 1179.46±256.23 | 70(75.3) | 23(24.7) | 1(1.1) | 92(98.9) | |||||||||||||||||||||||
| 非BPD组 | 165 | 84(50.9) | 81(49.1) | 42.82±11.98 | 210.67±8.78 | 1312.79±226.62 | 120(72.7) | 45(27.3) | 1(0.6) | 164(99.4) | |||||||||||||||||||||||
| χ2/t/Z值 | 5.209 | -6.371 | -4.445 | -4.326 | 0.198 | - | |||||||||||||||||||||||||||
| P值 | 0.022 | 0.000 | 0.000 | 0.000 | 0.656 | 1.000 | |||||||||||||||||||||||||||
| 组别 | 胎膜早破[例(%)] | 产前激素[例(%)] | 羊水情况[例(%)] | 胎盘[例(%)] | 脐带[例(%)] | ||||||||||||||||||||||||||||
| 是 | 否 | 是 | 否 | 正常 | 异常 | 正常 | 异常 | 正常 | 异常 | ||||||||||||||||||||||||
| BPD组 | 19(20.4) | 74(79.6) | 82(88.2) | 11(11.8) | 67(72.0) | 26(28.0) | 78(83.9) | 15(16.1) | 81(87.1) | 12(12.9) | |||||||||||||||||||||||
| 非BPD组 | 47(28.5) | 118(71.5) | 150(90.9) | 15(9.1) | 124(75.2) | 41(24.8) | 152(92.1) | 13(7.9) | 150(90.9) | 15(9.1) | |||||||||||||||||||||||
| χ2/t/Z值 | 2.027 | 0.492 | 0.299 | 4.184 | 0.923 | ||||||||||||||||||||||||||||
| P值 | 0.155 | 0.483 | 0.585 | 0.041 | 0.337 | ||||||||||||||||||||||||||||
| 组别 | Apgar评分(分) | 呼吸机(d) | PS使用情况[例(%)] | 合并疾病(PDA、PPHN、 ROP等)[例(%)] | |||||||||||||||||||||||||||||
| 1分钟 | 5分钟 | 10分钟 | 有创 | 无创 | 是 | 否 | 是 | 否 | |||||||||||||||||||||||||
| BPD组 | 6.68±2.38 | 8.19±1.87 | 9.74±0.74 | 9.37±12.78 | 20.40±15.69 | 81(87.1) | 12(12.9) | 41(44.1) | 52(55.9) | ||||||||||||||||||||||||
| 非BPD组 | 7.62±2.34 | 8.67±1.93 | 9.47±1.36 | 1.24±2.13 | 11.34±11.10 | 104(63.0) | 61(37.0) | 35(21.2) | 130(78.8) | ||||||||||||||||||||||||
| χ2/t/Z值 | -3.569 | -2.743 | -1.726 | -7.500 | -5.893 | 16.979 | 14.976 | ||||||||||||||||||||||||||
| P值 | 0.000 | 0.006 | 0.084 | 0.000 | 0.000 | 0.000 | 0.000 | ||||||||||||||||||||||||||
表1 两组一般资料比较
Tab.1 General information between groups
| 组别 | 例数 | 性别[例(%)] | 住院时间 (d) | 胎龄 (d) | 出生体重 (g) | 母孕期合并疾病[例(%)] | 母绒毛膜羊膜炎[例(%)] | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 是 | 否 | 是 | 否 | ||||||||||||||||||||||||||||
| BPD组 | 93 | 61(65.6) | 32(34.4) | 54.91±16.19 | 204.11±12.59 | 1179.46±256.23 | 70(75.3) | 23(24.7) | 1(1.1) | 92(98.9) | |||||||||||||||||||||||
| 非BPD组 | 165 | 84(50.9) | 81(49.1) | 42.82±11.98 | 210.67±8.78 | 1312.79±226.62 | 120(72.7) | 45(27.3) | 1(0.6) | 164(99.4) | |||||||||||||||||||||||
| χ2/t/Z值 | 5.209 | -6.371 | -4.445 | -4.326 | 0.198 | - | |||||||||||||||||||||||||||
| P值 | 0.022 | 0.000 | 0.000 | 0.000 | 0.656 | 1.000 | |||||||||||||||||||||||||||
| 组别 | 胎膜早破[例(%)] | 产前激素[例(%)] | 羊水情况[例(%)] | 胎盘[例(%)] | 脐带[例(%)] | ||||||||||||||||||||||||||||
| 是 | 否 | 是 | 否 | 正常 | 异常 | 正常 | 异常 | 正常 | 异常 | ||||||||||||||||||||||||
| BPD组 | 19(20.4) | 74(79.6) | 82(88.2) | 11(11.8) | 67(72.0) | 26(28.0) | 78(83.9) | 15(16.1) | 81(87.1) | 12(12.9) | |||||||||||||||||||||||
| 非BPD组 | 47(28.5) | 118(71.5) | 150(90.9) | 15(9.1) | 124(75.2) | 41(24.8) | 152(92.1) | 13(7.9) | 150(90.9) | 15(9.1) | |||||||||||||||||||||||
| χ2/t/Z值 | 2.027 | 0.492 | 0.299 | 4.184 | 0.923 | ||||||||||||||||||||||||||||
| P值 | 0.155 | 0.483 | 0.585 | 0.041 | 0.337 | ||||||||||||||||||||||||||||
| 组别 | Apgar评分(分) | 呼吸机(d) | PS使用情况[例(%)] | 合并疾病(PDA、PPHN、 ROP等)[例(%)] | |||||||||||||||||||||||||||||
| 1分钟 | 5分钟 | 10分钟 | 有创 | 无创 | 是 | 否 | 是 | 否 | |||||||||||||||||||||||||
| BPD组 | 6.68±2.38 | 8.19±1.87 | 9.74±0.74 | 9.37±12.78 | 20.40±15.69 | 81(87.1) | 12(12.9) | 41(44.1) | 52(55.9) | ||||||||||||||||||||||||
| 非BPD组 | 7.62±2.34 | 8.67±1.93 | 9.47±1.36 | 1.24±2.13 | 11.34±11.10 | 104(63.0) | 61(37.0) | 35(21.2) | 130(78.8) | ||||||||||||||||||||||||
| χ2/t/Z值 | -3.569 | -2.743 | -1.726 | -7.500 | -5.893 | 16.979 | 14.976 | ||||||||||||||||||||||||||
| P值 | 0.000 | 0.006 | 0.084 | 0.000 | 0.000 | 0.000 | 0.000 | ||||||||||||||||||||||||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 233.85±73.10 | 244.85±125.17 | 262.16±124.16*# | 333.19±126.46* |
| 非BPD组 | 165 | 239.73±66.82 | 270.87±113.68* | 301.85±133.02* | 335.74±123.32* |
| 组间 | F=2.990 P=0.096 | ||||
| 时点间 | F=57.391 P=0.000 | ||||
| 组间·时点间 | F=2.485 P=0.064 | ||||
表2 两组PLT比较
Tab.2 PLT between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 233.85±73.10 | 244.85±125.17 | 262.16±124.16*# | 333.19±126.46* |
| 非BPD组 | 165 | 239.73±66.82 | 270.87±113.68* | 301.85±133.02* | 335.74±123.32* |
| 组间 | F=2.990 P=0.096 | ||||
| 时点间 | F=57.391 P=0.000 | ||||
| 组间·时点间 | F=2.485 P=0.064 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 9.98±0.95 | 11.29±1.17*# | 11.66±1.11* | 11.18±1.01* |
| 非BPD组 | 165 | 9.80±1.77 | 10.94±1.35* | 11.38±1.31* | 11.12±1.26* |
| 组间 | F=3.039 P=0.082 | ||||
| 时点间 | F=115.192 P=0.000 | ||||
| 组间·时点间 | F=0.889 P=0.434 | ||||
表3 两组MPV比较
Tab.3 MPV between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 9.98±0.95 | 11.29±1.17*# | 11.66±1.11* | 11.18±1.01* |
| 非BPD组 | 165 | 9.80±1.77 | 10.94±1.35* | 11.38±1.31* | 11.12±1.26* |
| 组间 | F=3.039 P=0.082 | ||||
| 时点间 | F=115.192 P=0.000 | ||||
| 组间·时点间 | F=0.889 P=0.434 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 | |
|---|---|---|---|---|---|---|
| BPD组 | 93 | 12.20±2.88# | 14.63±3.33* | 15.61±2.78* | 14.38±2.80* | |
| 非BPD组 | 165 | 13.61±3.11 | 14.87±2.87* | 15.30±3.14* | 14.74±2.72* | |
| 组间 | F=1.956 P=0.163 | |||||
| 时点间 | F=62.641 P=0.000 | |||||
| 组间·时点间 | F=6.888 P=0.000 | |||||
表4 两组PDW比较
Tab.4 PDW between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 | |
|---|---|---|---|---|---|---|
| BPD组 | 93 | 12.20±2.88# | 14.63±3.33* | 15.61±2.78* | 14.38±2.80* | |
| 非BPD组 | 165 | 13.61±3.11 | 14.87±2.87* | 15.30±3.14* | 14.74±2.72* | |
| 组间 | F=1.956 P=0.163 | |||||
| 时点间 | F=62.641 P=0.000 | |||||
| 组间·时点间 | F=6.888 P=0.000 | |||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 0.23±0.06 | 0.28±0.12* | 0.31±0.12* | 0.37±0.12* |
| 非BPD组 | 165 | 0.23±0.07 | 0.29±0.12* | 0.34±0.13* | 0.36±0.12* |
| 组间 | F=0.523 P=0.470 | ||||
| 时点间 | F=112.460 P=0.000 | ||||
| 组间·时点间 | F=2.423 P=0.068 | ||||
表5 两组PCT比较
Tab.5 PCT between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 0.23±0.06 | 0.28±0.12* | 0.31±0.12* | 0.37±0.12* |
| 非BPD组 | 165 | 0.23±0.07 | 0.29±0.12* | 0.34±0.13* | 0.36±0.12* |
| 组间 | F=0.523 P=0.470 | ||||
| 时点间 | F=112.460 P=0.000 | ||||
| 组间·时点间 | F=2.423 P=0.068 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 5.93±6.27 | 6.87±5.82 | 7.02±3.55 | 5.76±5.00# |
| 非BPD组 | 165 | 5.17±4.35 | 6.49±6.53* | 6.26±4.70* | 4.42±3.76 |
| 组间 | F=3.401 P=0.066 | ||||
| 时点间 | F=7.953 P=0.000 | ||||
| 组间·时点间 | F=0.496 P=0.671 | ||||
表6 两组NEUC比较
Tab.6 NEUC between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 5.93±6.27 | 6.87±5.82 | 7.02±3.55 | 5.76±5.00# |
| 非BPD组 | 165 | 5.17±4.35 | 6.49±6.53* | 6.26±4.70* | 4.42±3.76 |
| 组间 | F=3.401 P=0.066 | ||||
| 时点间 | F=7.953 P=0.000 | ||||
| 组间·时点间 | F=0.496 P=0.671 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 3.27±1.75# | 3.58±1.51 | 3.97±1.65* | 4.39±2.27* |
| 非BPD组 | 165 | 4.13±2.39 | 3.84±1.38 | 4.30±1.45 | 4.46±1.33 |
| 组间 | F=6.476 P=0.012 | ||||
| 时点间 | F=13.185 P=0.000 | ||||
| 组间·时点间 | F=3.059 P=0.039 | ||||
表7 两组LYC比较
Tab.7 LYC between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 3.27±1.75# | 3.58±1.51 | 3.97±1.65* | 4.39±2.27* |
| 非BPD组 | 165 | 4.13±2.39 | 3.84±1.38 | 4.30±1.45 | 4.46±1.33 |
| 组间 | F=6.476 P=0.012 | ||||
| 时点间 | F=13.185 P=0.000 | ||||
| 组间·时点间 | F=3.059 P=0.039 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 2.05±2.19# | 1.91±1.27 | 2.59±5.19# | 2.20±5.88# |
| 非BPD组 | 165 | 1.47±1.29 | 1.82±2.03 | 1.64±1.47 | 1.09±0.96 |
| 组间 | F=8.133 P=0.005 | ||||
| 时点间 | F=1.739 P=0.182 | ||||
| 组间·时点间 | F=2.193 P=0.121 | ||||
表8 两组NLR比较
Tab.8 NLR between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 2.05±2.19# | 1.91±1.27 | 2.59±5.19# | 2.20±5.88# |
| 非BPD组 | 165 | 1.47±1.29 | 1.82±2.03 | 1.64±1.47 | 1.09±0.96 |
| 组间 | F=8.133 P=0.005 | ||||
| 时点间 | F=1.739 P=0.182 | ||||
| 组间·时点间 | F=2.193 P=0.121 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 87.70±49.29# | 74.78±37.68* | 74.73±46.26* | 90.97±55.47 |
| 非BPD组 | 165 | 70.80±33.94 | 77.20±40.69 | 77.18±42.55 | 81.22±37.03* |
| 组间 | F=2.393 P=0.123 | ||||
| 时点间 | F=3.916 P=0.009 | ||||
| 组间·时点间 | F=3.929 P=0.009 | ||||
表9 两组PLR比较
Tab.9 PLR between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 87.70±49.29# | 74.78±37.68* | 74.73±46.26* | 90.97±55.47 |
| 非BPD组 | 165 | 70.80±33.94 | 77.20±40.69 | 77.18±42.55 | 81.22±37.03* |
| 组间 | F=2.393 P=0.123 | ||||
| 时点间 | F=3.916 P=0.009 | ||||
| 组间·时点间 | F=3.929 P=0.009 | ||||
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 2304.85±676.98 | 2728.50±1305.44* | 3015.30±1367.43*# | 3656.52±1288.96* |
| 非BPD组 | 165 | 2330.02±714.99 | 2937.44±1227.73* | 3364.44±1336.12* | 3650.21±1182.26* |
| 组间 | F=1.790 P=0.182 | ||||
| 时点间 | F=87.097 P=0.000 | ||||
| 组间·时点间 | F=1.889 P=0.135 | ||||
表10 两组PMI比较
Tab.10 PMI between groups
| 组别 | 例数 | 24 h | 1周 | 2周 | 4周 |
|---|---|---|---|---|---|
| BPD组 | 93 | 2304.85±676.98 | 2728.50±1305.44* | 3015.30±1367.43*# | 3656.52±1288.96* |
| 非BPD组 | 165 | 2330.02±714.99 | 2937.44±1227.73* | 3364.44±1336.12* | 3650.21±1182.26* |
| 组间 | F=1.790 P=0.182 | ||||
| 时点间 | F=87.097 P=0.000 | ||||
| 组间·时点间 | F=1.889 P=0.135 | ||||
| 影响因素 | 回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 性别 | -0.846 | 0.330 | 6.590 | 0.010 | 0.429 | 0.225 | 0.819 |
| 胎龄(d) | -0.038 | 0.018 | 4.723 | 0.030 | 0.962 | 0.930 | 0.996 |
| 出生体重(g) | -0.002 | 0.001 | 5.007 | 0.025 | 0.998 | 0.997 | 1.000 |
| 胎盘 | 0.508 | 0.467 | 1.183 | 0.277 | 1.662 | 0.665 | 4.151 |
| Apgar评分1 min | -0.167 | 0.079 | 4.501 | 0.034 | 0.846 | 0.725 | 0.987 |
| Apgar评分10 min | 0.458 | 0.200 | 5.250 | 0.022 | 1.581 | 1.069 | 2.340 |
| PLT24 h内 | 0.026 | 0.019 | 1.808 | 0.179 | 1.026 | 0.988 | 1.066 |
| MPV24 h内 | 0.629 | 0.456 | 1.904 | 0.168 | 1.876 | 0.768 | 4.587 |
| PDW24 h内 | -0.096 | 0.058 | 2.758 | 0.097 | 0.908 | 0.811 | 1.017 |
| PCT24 h内 | 2.514 | 3.551 | 0.501 | 0.479 | 12.355 | 0.012 | 13026 |
| NEUC24 h内 | -0.012 | 0.070 | 0.029 | 0.865 | 0.988 | 0.862 | 1.133 |
| LYC24 h内 | -0.106 | 0.143 | 0.550 | 0.458 | 0.899 | 0.679 | 1.190 |
| NLR24 h内 | 0.047 | 0.216 | 0.048 | 0.826 | 1.049 | 0.687 | 1.600 |
| PLR24 h内 | 0.006 | 0.008 | 0.486 | 0.486 | 1.006 | 0.990 | 1.022 |
| PMI24 h内 | -0.003 | 0.002 | 2.083 | 0.149 | 0.997 | 0.993 | 1.001 |
| 常量 | 2.377 | 6.264 | 0.144 | 0.704 | 10.770 | - | - |
表11 24 hBPD的多因素logistic回归分析
Tab.11 Logistic regression analysis of 24 hBPD
| 影响因素 | 回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 性别 | -0.846 | 0.330 | 6.590 | 0.010 | 0.429 | 0.225 | 0.819 |
| 胎龄(d) | -0.038 | 0.018 | 4.723 | 0.030 | 0.962 | 0.930 | 0.996 |
| 出生体重(g) | -0.002 | 0.001 | 5.007 | 0.025 | 0.998 | 0.997 | 1.000 |
| 胎盘 | 0.508 | 0.467 | 1.183 | 0.277 | 1.662 | 0.665 | 4.151 |
| Apgar评分1 min | -0.167 | 0.079 | 4.501 | 0.034 | 0.846 | 0.725 | 0.987 |
| Apgar评分10 min | 0.458 | 0.200 | 5.250 | 0.022 | 1.581 | 1.069 | 2.340 |
| PLT24 h内 | 0.026 | 0.019 | 1.808 | 0.179 | 1.026 | 0.988 | 1.066 |
| MPV24 h内 | 0.629 | 0.456 | 1.904 | 0.168 | 1.876 | 0.768 | 4.587 |
| PDW24 h内 | -0.096 | 0.058 | 2.758 | 0.097 | 0.908 | 0.811 | 1.017 |
| PCT24 h内 | 2.514 | 3.551 | 0.501 | 0.479 | 12.355 | 0.012 | 13026 |
| NEUC24 h内 | -0.012 | 0.070 | 0.029 | 0.865 | 0.988 | 0.862 | 1.133 |
| LYC24 h内 | -0.106 | 0.143 | 0.550 | 0.458 | 0.899 | 0.679 | 1.190 |
| NLR24 h内 | 0.047 | 0.216 | 0.048 | 0.826 | 1.049 | 0.687 | 1.600 |
| PLR24 h内 | 0.006 | 0.008 | 0.486 | 0.486 | 1.006 | 0.990 | 1.022 |
| PMI24 h内 | -0.003 | 0.002 | 2.083 | 0.149 | 0.997 | 0.993 | 1.001 |
| 常量 | 2.377 | 6.264 | 0.144 | 0.704 | 10.770 | - | - |
| 影响因素 | 回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 性别 | -0.604 | 0.325 | 3.451 | 0.063 | 0.547 | 0.289 | 1.034 |
| 胎龄(d) | -0.035 | 0.018 | 3.935 | 0.047 | 0.966 | 0.933 | 1.000 |
| 出生体重(g) | -0.002 | 0.001 | 3.622 | 0.057 | 0.998 | 0.997 | 1.000 |
| 胎盘 | 0.547 | 0.477 | 1.314 | 0.252 | 1.728 | 0.678 | 4.400 |
| Apgar评分1 min | -0.199 | 0.078 | 6.541 | 0.011 | 0.820 | 0.704 | 0.955 |
| Apgar评分10 min | 0.588 | 0.211 | 7.755 | 0.005 | 1.801 | 1.190 | 2.724 |
| PLT1周 | 0.021 | 0.014 | 2.440 | 0.118 | 1.022 | 0.995 | 1.049 |
| MPV1周 | 0.720 | 0.343 | 4.396 | 0.036 | 2.054 | 1.048 | 4.026 |
| PDW1周 | -0.069 | 0.063 | 1.199 | 0.273 | 0.933 | 0.824 | 1.056 |
| PCT1周 | 16.871 | 7.001 | 5.808 | 0.016 | 21232742 | 23.333 | 19321170966829 |
| NEUC1周 | 0.065 | 0.059 | 1.202 | 0.273 | 1.067 | 0.950 | 1.199 |
| LYC1周 | -0.161 | 0.235 | 0.468 | 0.494 | 0.851 | 0.537 | 1.350 |
| NLR1周 | -0.340 | 0.203 | 2.819 | 0.093 | 0.712 | 0.478 | 1.059 |
| PLR1周 | 0.003 | 0.008 | 0.120 | 0.730 | 1.003 | 0.987 | 1.019 |
| PMI1周 | -0.004 | 0.002 | 5.352 | 0.021 | 0.996 | 0.993 | 0.999 |
| 常量 | -1.424 | 5.391 | 0.070 | 0.792 | 0.241 | - | - |
表12 1周BPD的多因素logistic回归分析
Tab.12 Logistic regression analysis of BPD at 1 week
| 影响因素 | 回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 性别 | -0.604 | 0.325 | 3.451 | 0.063 | 0.547 | 0.289 | 1.034 |
| 胎龄(d) | -0.035 | 0.018 | 3.935 | 0.047 | 0.966 | 0.933 | 1.000 |
| 出生体重(g) | -0.002 | 0.001 | 3.622 | 0.057 | 0.998 | 0.997 | 1.000 |
| 胎盘 | 0.547 | 0.477 | 1.314 | 0.252 | 1.728 | 0.678 | 4.400 |
| Apgar评分1 min | -0.199 | 0.078 | 6.541 | 0.011 | 0.820 | 0.704 | 0.955 |
| Apgar评分10 min | 0.588 | 0.211 | 7.755 | 0.005 | 1.801 | 1.190 | 2.724 |
| PLT1周 | 0.021 | 0.014 | 2.440 | 0.118 | 1.022 | 0.995 | 1.049 |
| MPV1周 | 0.720 | 0.343 | 4.396 | 0.036 | 2.054 | 1.048 | 4.026 |
| PDW1周 | -0.069 | 0.063 | 1.199 | 0.273 | 0.933 | 0.824 | 1.056 |
| PCT1周 | 16.871 | 7.001 | 5.808 | 0.016 | 21232742 | 23.333 | 19321170966829 |
| NEUC1周 | 0.065 | 0.059 | 1.202 | 0.273 | 1.067 | 0.950 | 1.199 |
| LYC1周 | -0.161 | 0.235 | 0.468 | 0.494 | 0.851 | 0.537 | 1.350 |
| NLR1周 | -0.340 | 0.203 | 2.819 | 0.093 | 0.712 | 0.478 | 1.059 |
| PLR1周 | 0.003 | 0.008 | 0.120 | 0.730 | 1.003 | 0.987 | 1.019 |
| PMI1周 | -0.004 | 0.002 | 5.352 | 0.021 | 0.996 | 0.993 | 0.999 |
| 常量 | -1.424 | 5.391 | 0.070 | 0.792 | 0.241 | - | - |
| [1] | Northway WJ, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia[J]. N Engl J Med, 1967, 276(7):357-368. |
| [2] |
Thebaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia[J]. Nat Rev Dis Primers, 2019, 5(1):78.
doi: 10.1038/s41572-019-0127-7 pmid: 31727986 |
| [3] | Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach[J]. Am J Respir Crit Care Med, 2019, 200(6):751-759. |
| [4] |
Wang X, Ma Y, Wang S, et al. Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: An observational cohort study[J]. BMC Pulm Med, 2022, 22(1):109.
doi: 10.1186/s12890-022-01895-2 pmid: 35346143 |
| [5] | Zhu Z, He Y, Yuan L, et al. Trends in bronchopulmonary dysplasia and respiratory support among extremely preterm infants in China over a decade[J]. Pediatr Pulmonol, 2024, 59(2):399-407. |
| [6] | Lingappan K, Jiang W, Wang L, et al. Sex-specific differences in neonatal hyperoxic lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2016, 311(2):L481-L493. |
| [7] | Cantu A, Gutierrez MC, Dong X, et al. Remarkable sex-specific differences at single-cell resolution in neonatal hyperoxic lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2023, 324(1):L5-L31. |
| [8] | 张慧, 韩彤妍, 朴梅花, 等. 1 min低Apgar评分超早产儿/超低出生体重儿的远期结局[J]. 中华围产医学杂志, 2017, 20(5):366-370. |
| [9] | Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375:n1974. |
| [10] | El-Saie A, Varghese NP, Webb MK, et al. Bronchopulmonary dysplasia - associated pulmonary hypertension: An updated review[J]. Semin Perinatol, 2023, 47(6):151817. |
| [11] |
Ramos-Navarro C, Gregorio-Hernández R, Pérez-Pérez A, et al. Impact of placental pathology on the risk of bronchopulmonary dysplasia in preterm infants: The role of gestational age and sex[J]. Eur J Pediatr, 2025, 184(3):211.
doi: 10.1007/s00431-025-06016-9 pmid: 40009187 |
| [12] |
Li T, Xia B, Liang S, et al. Right ventricular function indices and platelet parameters for early prediction value of bronchopulmonary dysplasia: A retrospective study[J]. BMC Pediatr, 2024, 24(1):391.
doi: 10.1186/s12887-024-04868-y pmid: 38862972 |
| [13] | Yan L, Ren Z, Wang J, et al. The correlation between bronchopulmonary dysplasia and platelet metabolism in preterm infants[J]. Front Pediatr, 2021, 9:670469. |
| [14] | Chen X, Zhong J, Han D, et al. Close association between platelet biogenesis and alveolarization of the developing lung[J]. Front Pediatr, 2021, 9:625031. |
| [15] |
Chen X, Li H, Qiu X, et al. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants[J]. BMC Pediatr, 2019, 19(1):138.
doi: 10.1186/s12887-019-1515-6 pmid: 31039810 |
| [16] | Jiang J, Mao Y, Wu J, et al. Relationship between hematological parameters and bronchopulmonary dysplasia in premature infants[J]. J Int Med Res, 2023, 51(7):655718566. |
| [17] |
Theilmeier G, Lenaerts T, Remacle C, et al. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress[J]. Blood, 1999, 94(8):2725-2734.
pmid: 10515876 |
| [18] |
Okur N, Buyuktiryaki M, Uras N, et al. Platelet mass index in very preterm infants: Can it be used as a parameter for neonatal morbidities?[J]. J Matern Fetal Neonatal Med, 2016, 29(19):3218-3222.
doi: 10.3109/14767058.2015.1121475 pmid: 26697923 |
| [19] | 鲁炜慧, 徐莉敏, 吕勤, 等. 淋巴细胞亚群与早产儿支气管肺发育不良的关系[J]. 现代实用医学, 2019, 31(7):893-895. |
| [20] | 杨智全, 王海青, 支更花, 等. TGF-β1水平和Treg数量对早产儿支气管肺发育不良的预测价值[J]. 临床和实验医学杂志, 2020, 19(1):85-88. |
| [21] |
Sun Y, Chen C, Zhang X, et al. High neutrophil-to-lymphocyte ratio is an early predictor of bronchopulmonary dysplasia[J]. Front Pediatr, 2019, 7:464.
doi: 10.3389/fped.2019.00464 pmid: 31781524 |
| [22] | Zhang S, Luan X, Zhang W, et al. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio as predictive biomarkers for early-onset neonatal sepsis[J]. J Coll Physicians Surg Pak, 2021, 31(7):821-824. |
| [23] |
Oak P, Hilgendorff A. The BPD trio? Interaction of dysregulated PDGF, VEGF, and TGF signaling in neonatal chronic lung disease[J]. Mol Cell Pediatr, 2017, 4(1):11.
doi: 10.1186/s40348-017-0076-8 pmid: 29116547 |
| [24] | Mariduena J, Ramagopal M, Hiatt M, et al. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants[J]. J Matern Fetal Neonatal Med, 2022, 35(8):1517-1522. |
| [25] | Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung[J]. Am J Physiol Lung Cell Mol Physiol, 2000, 279(3):L600-L607. |
| [26] | Yie TA, Loomis CA, Nowatzky J, et al. Hedgehog and platelet-derived growth factor signaling intersect during postnatal lung development[J]. Am J Respir Cell Mol Biol, 2023, 68(5):523-536. |
| [27] |
Tsukiji N, Inoue O, Morimoto M, et al. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction[J]. Blood, 2018, 132(11):1167-1179.
doi: 10.1182/blood-2017-12-823369 pmid: 29853539 |
| [28] | Syed MA, Choo-Wing R, Homer RJ, et al. Role of nitric oxide isoforms in vascular and alveolar development and lung injury in vascular endothelial growth factor overexpressing neonatal mice lungs[J]. PLoS One, 2016, 11(1):e147588. |
| [29] | Huang Z, Lin B, Han D, et al. Platelets are indispensable for alveolar development in neonatal mice[J]. Front Pediatr, 2022, 10:943054. |
| [30] | Dib P, Quirino-Teixeira AC, Merij LB, et al. Innate immune receptors in platelets and platelet-leukocyte interactions[J]. J Leukoc Biol, 2020, 108(4):1157-1182. |
| [31] | Dahlgren C, Lind S, Martensson J, et al. G protein coupled pattern recognition receptors expressed in neutrophils: Recognition, activation/modulation, signaling and receptor regulated functions[J]. Immunol Rev, 2023, 314(1):69-92. |
| [32] |
Xu X, Wang Y, Tao Y, et al. The role of platelets in sepsis: A review[J]. Biomol Biomed, 2024, 24(4):741-752.
doi: 10.17305/bb.2023.10135 pmid: 38236204 |
| [33] | Sati SK, Springer C, Kim R, et al. Platelet parameters as biomarker for bronchopulmonary dysplasia in very low birth weight neonates in the first two weeks of life[J]. Minerva Pediatr (Torino), 2023, 5. |
| [34] |
Papayannopoulos V. Neutrophil extracellular traps in immunity and disease[J]. Nat Rev Immunol, 2018, 18(2):134-147.
doi: 10.1038/nri.2017.105 pmid: 28990587 |
| [35] | Denning NL, Aziz M, Gurien SD, et al. DAMPs and NETs in Sepsis[J]. Front Immunol, 2019, 10:2536. |
| [1] | 魏静, 崔清洋, 韩慧珍, 闫会丽, 刘庆生. 支气管肺发育不良合并肺动脉高压早产儿血清IL-33表达水平及其临床意义[J]. 临床荟萃, 2025, 40(5): 445-449. |
| [2] | 赵一品, 崔清洋. 超早产儿/超低出生体重儿支气管肺发育不良危险因素分析[J]. 临床荟萃, 2025, 40(1): 60-64. |
| [3] | 张红梅;杨爱云;丁玉慧. 网织血小板及血小板参数在血小板减少性疾病中的诊断价值[J]. 临床荟萃, 2011, 26(7): 604-605. |
| [4] | 武湘云;刘书艳;张晓琳;孙桂兰. 创伤性休克患者血小板参数的动态变化及其意义[J]. 临床荟萃, 2010, 25(20): 1822-1823. |
| [5] | 李燕;潘新年;范歆;陈瑜毅. 早产儿视网膜病危险因素及发病情况分析[J]. 临床荟萃, 2010, 25(13): 1180-1182. |
| [6] | 吴亚杰;吕新湖;薛铮. 冠心病及高血压患者血小板参数变化及临床意义[J]. 临床荟萃, 2009, 24(24): 2155-2156. |
| [7] | 秦天娥;陈小燕;王茂筠. 卡塔格内综合征[J]. 临床荟萃, 2006, 21(20): 1517-1518. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||